US Stock MarketDetailed Quotes
LFCR Lifecore Biomedical
- 7.310
- +0.330+4.73%
Close Nov 22 16:00 ET
- 7.310
- 0.0000.00%
Post 20:01 ET
269.21MMarket Cap52.21P/E (TTM)
7.455High7.055Low207.49KVolume7.140Open6.980Pre Close1.51MTurnover0.95%Turnover Ratio22.84P/E (Static)36.83MShares8.90052wk High-68.32P/B160.45MFloat Cap3.67952wk Low--Dividend TTM21.95MShs Float16.750Historical High--Div YieldTTM5.73%Amplitude1.510Historical Low7.280Avg Price1Lot Size
Lifecore Biomedical Key Stats
Quarterly+Annual
YOY
| (Q1)Aug 25, 2024 | (FY)May 26, 2024 | (Q4)May 26, 2024 | (Q3)Feb 25, 2024 | (Q2)Nov 26, 2023 | (Q1)Aug 27, 2023 | (FY)May 28, 2023 | (Q4)May 28, 2023 | (Q3)Feb 26, 2023 | (Q2)Nov 27, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.75%24.71M | 24.20%128.26M | 21.64%37.89M | 34.55%35.7M | 37.90%30.15M | 3.36%24.52M | -7.19%103.27M | 47.40%31.15M | -29.05%26.54M | -49.68%21.86M |
| Operating revenue | 0.75%24.71M | 24.20%128.26M | 21.64%37.89M | 34.55%35.7M | 37.90%30.15M | 3.36%24.52M | -7.19%103.27M | 47.40%31.15M | -29.05%26.54M | -49.68%21.86M |
| Cost of revenue | -11.36%19.32M | 14.78%86.41M | -11.78%20.61M | 32.37%23.81M | 24.76%20.19M | 22.82%21.79M | 4.27%75.28M | 70.60%23.37M | -26.68%17.99M | -43.68%16.19M |
| Gross profit | 97.47%5.39M | 49.54%41.85M | 122.03%17.27M | 39.14%11.89M | 75.33%9.96M | -54.37%2.73M | -28.36%27.99M | 4.65%7.78M | -33.56%8.55M | -61.41%5.68M |
| Operating expense | 45.24%16.49M | 2.79%49.04M | -0.17%14.39M | -3.96%12.02M | 7.79%11.28M | 10.06%11.35M | 12.25%47.71M | 58.05%14.41M | -22.58%12.51M | 6.08%10.47M |
| Selling and administrative expenses | 55.36%14.3M | 3.83%40.46M | -0.57%12.22M | -4.19%9.85M | 10.78%9.19M | 13.61%9.21M | 12.44%38.97M | 75.63%12.29M | -27.42%10.28M | 3.48%8.29M |
| Research and development costs | 1.86%2.19M | -1.84%8.58M | 2.17%2.16M | -2.86%2.17M | -3.63%2.1M | -2.94%2.15M | 11.44%8.74M | -0.09%2.12M | 11.70%2.23M | 17.30%2.18M |
| Operating profit | -28.72%-11.1M | 63.55%-7.19M | 143.54%2.89M | 96.87%-124K | 72.31%-1.33M | -98.94%-8.62M | -474.59%-19.72M | -293.71%-6.63M | -20.26%-3.97M | -198.80%-4.79M |
| Net non-operating interest income expense | -36.31%-5.37M | -2.90%-18.09M | 2.01%-5.79M | 11.26%-4.29M | -12.89%-4.07M | -21.88%-3.94M | -13.65%-17.58M | -256.18%-5.91M | -18.31%-4.83M | -17.33%-3.61M |
| Non-operating interest expense | 36.31%5.37M | 2.90%18.09M | -2.01%5.79M | -11.26%4.29M | 12.89%4.07M | 21.88%3.94M | 13.65%17.58M | 270.94%5.91M | 17.73%4.83M | 16.61%3.61M |
| Other net income (expense) | 435.00%214K | 230.66%34.79M | 82.50%-4.24M | 888.59%19.42M | 2,547.00%19.58M | -95.37%40K | -1,391.71%-26.63M | -6,448.38%-24.23M | -474.73%-2.46M | -27.39%-800K |
| Gain on sale of security | 350.00%900K | --39.5M | ---2.4M | --21M | --20.7M | --200K | ---- | ---- | ---- | ---- |
| Special income (charges) | -4,930.00%-483K | 93.59%-1.66M | 96.89%-738K | 69.95%-771K | 72.11%-157K | -99.06%10K | -208.85%-25.82M | -2,764.78%-23.75M | 51.31%-2.57M | 20.37%-563K |
| -Less：Restructuring and merger&acquisition | 4,930.00%483K | -60.42%1.66M | 9,125.00%738K | -69.95%771K | -72.11%157K | -100.96%-10K | -49.95%4.18M | -99.03%8K | -51.31%2.57M | -20.37%563K |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | --23.74M | ---- | ---- | ---- |
| -Gain on sale of business | ---- | --0 | --0 | --0 | --0 | ---- | --2.11M | --0 | --0 | --0 |
| Other non- operating income (expenses) | -19.41%-203K | -276.79%-3.05M | -129.58%-1.1M | -882.69%-814K | -308.02%-967K | 14.14%-170K | -112.32%-810K | -204.58%-480K | -98.25%104K | -400.00%-237K |
| Income before tax | -29.81%-16.26M | 114.88%9.51M | 80.57%-7.14M | 233.23%15M | 254.15%14.18M | -86.81%-12.52M | -209.02%-63.93M | -890.25%-36.77M | -67.43%-11.26M | -903.93%-9.2M |
| Income tax | -128.41%-25K | -40.58%183K | -124.78%-57K | 210.00%217K | -1,725.00%-65K | 2,100.00%88K | 105.91%308K | -39.47%230K | 180.46%70K | 100.13%4K |
| Net income | -50.92%-16.23M | 112.07%12.01M | 81.97%-7.08M | 142.82%15.63M | 211.03%14.22M | 1.93%-10.75M | 14.70%-99.56M | 29.34%-39.28M | -178.98%-36.51M | 66.69%-12.81M |
| Net income continuous Operations | -28.71%-16.23M | 114.53%9.33M | 80.85%-7.09M | 230.49%14.79M | 254.79%14.24M | -88.01%-12.61M | -315.07%-64.24M | -803.93%-37M | -70.68%-11.33M | -317.57%-9.2M |
| Net income discontinuous operations | --0 | 107.59%2.68M | 100.13%3K | 103.36%847K | 99.33%-24K | 143.58%1.86M | 65.11%-35.33M | 95.56%-2.29M | -290.46%-25.18M | 91.55%-3.61M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -50.92%-16.23M | 112.07%12.01M | 81.97%-7.08M | 142.82%15.63M | 211.03%14.22M | 1.93%-10.75M | 14.70%-99.56M | 29.34%-39.28M | -178.98%-36.51M | 66.69%-12.81M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -50.92%-16.23M | 112.07%12.01M | 81.97%-7.08M | 142.82%15.63M | 211.03%14.22M | 1.93%-10.75M | 14.70%-99.56M | 29.34%-39.28M | -178.98%-36.51M | 66.69%-12.81M |
| Basic earnings per share | -51.43%-0.53 | 112.05%0.4 | 80.67%-0.23 | 142.50%0.51 | 209.30%0.47 | 5.41%-0.35 | 16.37%-3.32 | 3.70%-1.19 | -166.67%-1.2 | 66.92%-0.43 |
| Diluted earnings per share | -51.43%-0.53 | 109.64%0.32 | 80.67%-0.23 | 135.00%0.42 | 190.70%0.39 | 5.41%-0.35 | 16.37%-3.32 | 4.03%-1.19 | -166.67%-1.2 | 66.92%-0.43 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data